🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Swiss Dermatology Network of Targeted Therapies (SDNTT)

Recruitingn/aAges 18 Years - anyAllSwiss Dermatology Network for Targeted Therapies
NCT01706692 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to evaluate the long-term course of patients with psoriasis and psoriatic-arthritis in systemic treatments such as, methotrexate, cyclosporin A, fumaric acids, acitretin, systemic PUVA, etanercept, infliximab, adalimumab and ustekinumab. A patient will be included at first initiation of the treatment and will remain in the registry for 10 years, regardless of subsequent therapy. The registry will also evaluate safety clinical outcomes and health related quality of life.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with diagnosis of plaque-type psoriasis or psoriasis arthritis confirmed by a dermatologist, * age ≥ 18, * Being administered a specific biologic/conventional systemic drug for the first time * Sufficient language skills (German, French, Italian and English) for the informed consent to participate * Informed consent to participate Exclusion Criteria: * Lack of informed consent * Patients being participants of clinical trials at the day of registration to the registry (if a patient is included into a clinical trial during the registry follow-ups, the patient data will be recorded, but analyzed separately)
💊

What it tests

  • Adalimumab
  • Etanercept
  • Infliximab
  • Ustekinumab
  • Cyclosporine A
📍

Where

6 sites
Aarau Cantonal Hospital
Aarau, Switzerland
Basel University Hospital
Basel, Switzerland
Inselspital - Bern University Hospital
Bern, Switzerland
Centre Hospitalier Universitaire Vaudois (CHUV)
Lausanne, Switzerland
St. Gallen Cantonal Hospital
Sankt Gallen, Switzerland
Zurich University Hospital
Zurich, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy